A review links changes in how immune cells use energy to inflammation in MS and other autoimmune diseases.
The review describes how changes in immune cells' energy use may help drive inflammation in MS. It also covers rheumatoid arthritis and type 1 diabetes. Changes in how these cells use sugar and fat may affect how they respond. The authors describe similar changes in lupus, another disease in which the immune system attacks the body. They suggest these changes as possible treatment targets, but this review did not test a treatment.
This review covers research on immune cells in MS and several other autoimmune diseases. It does not focus on one form of MS. People with MS may be interested because the review examines how immune cells may contribute to inflammation. It also discusses research on rheumatoid arthritis, type 1 diabetes, and lupus. The authors note that treatments aimed at these cell changes could affect other parts of the body.
This review does not report a number of study participants. It brings together existing research rather than testing a treatment. It does not show whether changing how immune cells use energy helps people with MS.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/8/2026
A rare MS-like illness in one man may point to an immune system problem. Learn what this early findi
Read More10/8/2026
A teen recovered from sudden vision loss caused by an MS look-alike. Learn why urgent care and the r
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cellular & molecular immunology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.